HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Cutting cost of third level education must be Government priority – Fine Gael Senators
Fine Gael Senators have tabled a motion to be debated in the Seanad this week urging the Government to continue…
5th May 2025Tánaiste appoints Frank Feighan TD Fine Gael Spokesperson on Northern Ireland and on UK relations
Tánaiste and Fine Gael leader Simon Harris has appointed Frank Feighan TD Fine Gael Spokesperson on Northern Ireland and on…
2nd May 2025Tánaiste welcomes election of Mairead McGuinness as Vice President of the EPP
Tánaiste Simon Harris has today welcomed the election of Mairead McGuinness as Vice-President of the European People’s Party (EPP). Speaking…
30th April 2025